These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 16582867

  • 21. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E, Christakou C, Kandarakis H.
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [Abstract] [Full Text] [Related]

  • 22. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R, Gambineri A, Pagotto U.
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [Abstract] [Full Text] [Related]

  • 23. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ.
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [Abstract] [Full Text] [Related]

  • 24. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A.
    Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
    [Abstract] [Full Text] [Related]

  • 25. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.
    Chen MJ, Yang WS, Yang JH, Hsiao CK, Yang YS, Ho HN.
    Hum Reprod; 2006 Sep; 21(9):2266-71. PubMed ID: 16757555
    [Abstract] [Full Text] [Related]

  • 26. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF.
    Arch Intern Med; 2006 Oct 23; 166(19):2081-6. PubMed ID: 17060537
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
    Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I.
    Fertil Steril; 2011 Nov 23; 96(5):1271-4. PubMed ID: 21872228
    [Abstract] [Full Text] [Related]

  • 28. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
    Rahmanpour H, Jamal L, Mousavinasab SN, Esmailzadeh A, Azarkhish K.
    J Pediatr Adolesc Gynecol; 2012 Jun 23; 25(3):208-12. PubMed ID: 22578482
    [Abstract] [Full Text] [Related]

  • 29. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A, Amato MC, Giordano C.
    Nutr Metab Cardiovasc Dis; 2008 Sep 23; 18(7):511-8. PubMed ID: 18657405
    [Abstract] [Full Text] [Related]

  • 30. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Macut D, Kandaraki EA, Tsourdi EA, Papadakis E, Katsikis I.
    Gynecol Endocrinol; 2013 Oct 23; 29(10):926-30. PubMed ID: 23885694
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A.
    Semin Reprod Med; 2008 Jan 23; 26(1):39-44. PubMed ID: 18181081
    [Abstract] [Full Text] [Related]

  • 32. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Jan 23; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 33. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY, Wild RA.
    Semin Reprod Med; 2009 Jul 23; 27(4):299-305. PubMed ID: 19530063
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E, Economou F.
    Ann N Y Acad Sci; 2006 Nov 23; 1083():54-62. PubMed ID: 17148733
    [Abstract] [Full Text] [Related]

  • 37. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW, Nestler JE.
    Panminerva Med; 2008 Dec 23; 50(4):295-304. PubMed ID: 19078870
    [Abstract] [Full Text] [Related]

  • 38. Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome.
    Margolin E, Zhornitzki T, Kopernik G, Kogan S, Schattner A, Knobler H.
    Maturitas; 2005 Apr 11; 50(4):331-6. PubMed ID: 15780534
    [Abstract] [Full Text] [Related]

  • 39. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
    Pasquali R, Gambineri A.
    Ann N Y Acad Sci; 2006 Dec 11; 1092():158-74. PubMed ID: 17308142
    [Abstract] [Full Text] [Related]

  • 40. Polycystic ovary syndrome and the postmenopausal woman.
    Ireland K, Child T.
    J Br Menopause Soc; 2006 Dec 11; 12(4):143-8. PubMed ID: 17178014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.